Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study-Reference-Cited by-同舟云学术

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study

Published:2023-10 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Rajwa Pawel^ORCID,Robesti Daniele,Chaloupka Michael,Zattoni Fabio,Giesen Alexander,Huebner Nicolai A.,Krzywon Aleksandra,Miszczyk Marcin,Moll Matthias,Stando Rafał,Cisero Edoardo,Semko Sofiya,Checcucci Enrico,Devos Gaëtan,Apfelbeck Maria,Gatti Cecilia,Marra Giancarlo,van den Bergh Roderick C.N.,Goldner Gregor,Rasul Sazan,Ceci Francesco,Dal Moro Fabrizio,Porpiglia Francesco,Gontero Paolo,Bjartell Anders,Stief Christian,Heidenreich Axel,Joniau Steven,Briganti Alberto,Shariat Shahrokh F.,Gandaglia Giorgio

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference41 articles.

1. National comprehensive Cancer Network. Prostate cancer (version 1.2023). 2023. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.

2. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study;Hofman;Lancet,2020

3. PSMA ligand PET/MRI for primary prostate cancer: staging performance and clinical impact;Grubmuller;Clin Cancer Res,2018

4. Imaging-based prevalence of oligometastatic disease: a single-center cross-sectional study;Christ;Int J Radiat Oncol Biol Phys,2022

5. More accurate imaging is not stage migration: time to move from “hubble” to “webb” in hormone-sensitive prostate cancer;Ayati;Eur Urol,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Lutetium Radioligand Therapy in Prostate Cancer;Cancers;2024-07-01

2. Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006;European Urology Oncology;2024-06

3. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging;Current Opinion in Urology;2024-04-05

4. A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer;European Urology Oncology;2024-04

5. Management of oligometastatic prostate cancer;memo - Magazine of European Medical Oncology;2023-12-18